1977
DOI: 10.1128/aac.12.5.602
|View full text |Cite
|
Sign up to set email alerts
|

Systemic Metabolic Alterations Associated with Repeated Injections of a Modified Polyriboinosinic-Polyribocytidylic Acid Complex

Abstract: Polyriboinosinic acid-polyribocytidylic acid complexed with poly-l-lysine and injected intramuscularly into rats (0.3 or 3.0 mg/kg) produced fever, altered leukocyte count, slightly depressed plasma zinc, increased amino acid uptake into liver, and increased plasma acute-phase globulins two-to threefold. It is suggested that these systemic metabolic alterations are indicative of a mild inflammatory response to this drug. The metabolic alterations may have to be taken into consideration when polyriboinosinic ac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1980
1980
2021
2021

Publication Types

Select...
3
3

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 17 publications
(20 reference statements)
0
4
0
Order By: Relevance
“…A 2 to threefold increase in haptoglobin, and a dose dependent increase in alpha -2-macrofetoprotein. (Powanda et al, 1977 ).…”
Section: Use Of Acute Phase Proteins In Testing Anti-viral Drugsmentioning
confidence: 98%
See 1 more Smart Citation
“…A 2 to threefold increase in haptoglobin, and a dose dependent increase in alpha -2-macrofetoprotein. (Powanda et al, 1977 ).…”
Section: Use Of Acute Phase Proteins In Testing Anti-viral Drugsmentioning
confidence: 98%
“…Both 0.3 and 3.0 mg/kg poly(ICLC) caused increases in seromucoid (primarily consisting of alpha-1-acid glycoprotein and haptoglobin) up to five fold at 48 h. A 2 to threefold increase in haptoglobin, and a dose dependent increase in alpha -2-macrofetoprotein. (Powanda et al, 1977).…”
Section: Use Of Acute Phase Proteins In Testing Anti-viral Drugsmentioning
confidence: 99%
“…phor-hypoferremia by enhancing the flux of iron bol myristic acetate (20) and polyriboino-into the liver. Taken together these activities sinic-polyribocytidylic acid complexes (21). of LEM/EP/LAF may account, at least in as well as endotoxin (7) elicit LEM/EP/LAF part, for the observed antimicrobial activity release.…”
Section: Lajmentioning
confidence: 79%
“…There was no evidence of fever in any of the patients given either of the two treatments. Fever has been related to the use of polynucleotides designed for anti-viral therapy (Powanda et al 1977).…”
Section: Adverse Events and Safetymentioning
confidence: 99%